Lecanemab effectively targets amyloid plaques in people with Down syndrome, study finds

  • Post author:
  • Post category:uncategorized

People with Down syndrome are likely to develop Alzheimer’s disease at a young age, with autopsy studies showing that by age 40 years, the brains of individuals with Down syndrome have amyloid plaques.